Wire flash
PoliticsDr. Heidi Overton, President Trump's nominee to lead the Food and Drug Administration, faces significant opposition from Senate HELP Committee Chairman Bill Cassidy. Cassidy publicly questioned Overton's managerial experience and her role in a recent HHS executive order that would weaken vaccine requirements, calling the order 'nonsensical' and suggesting it could be 'almost disqualifying.' The White House is pushing for her confirmation, highlighting her work coordinating interagency policy on Trump's MAHA agenda and her credentials as a board-certified physician with a PhD from Johns Hopkins. Cassidy, who previously expressed doubts about HHS Secretary RFK Jr. and CDC Director Schwartz before voting to confirm them, holds the key to scheduling a hearing. The article notes the White House has previously withdrawn other nominees, including surgeon general picks Dr. Casey Means and Janette Nesheiwat, when confirmation appeared unlikely.
Government Executive - All ContentWestern
Trump nominates White House aide Heidi Overton to lead FDA amid controversy